Almudena González-Domínguez

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Iron Deficiency

Early Breast Cancer

Smoking Cessation

Respiratory Syndrome Coronavirus

Top Venues

PharmacoEconomics - open

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Health and quality of life outcomes

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Sergio Cedillo, Almudena González-Domínguez, Yoana Ivanova-Markova, Rafael López López, Sara López-Tarruella Cobo, José Alberto Peña Pedrosa
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain. PharmacoEconomics - open (2024)
Sergio Cedillo, Almudena González-Domínguez, Yoana Ivanova-Markova, Rafael López López, Sara López-Tarruella Cobo, José Alberto Peña Pedrosa
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain. PharmacoEconomics - open (2024)
Alejandro Soriano, Rocío Montejano, José Sanz-Moreno, Juan Carlos Figueira, Santiago Grau, Robert Güerri-Fernández, Antonio Castro-Gómez, Inés Pérez-Román, Álvaro Hidalgo-Vega, Almudena González-Domínguez
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain. Advances in therapy 38 (7) (2021)
Juan Francisco Delgado, Juan Oliva, Álvaro González Franco, Jose Maria Cepeda, José Ángel García-García, Almudena González-Domínguez, Albert Garcia-Casanovas, Silvia Jiménez Merino, Josep Comín Colet
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain. Journal of medical economics 23 (12) (2020)
Josep Comín-Colet, Teresa Martín Lorenzo, Almudena González-Domínguez, Juan Oliva, Silvia Jiménez Merino
Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review. Health and quality of life outcomes 18 (1) (2020)
Carlota Moya-Alarcón, Almudena González-Domínguez, Susana Simon, Inés Pérez-Román, Antonio González-Martín, Eloisa Bayo-Lozano, Ana Beatriz Sánchez-Heras
Cost-utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (8) (2019)